Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Alessandro Gamboni"'
Autor:
Laura Ridolfi, Lorena Gurrieri, Nada Riva, Jenny Bulgarelli, Francesco De Rosa, Massimo Guidoboni, Valentina Fausti, Nicoletta Ranallo, Sebastiano Calpona, Marcella Tazzari, Massimiliano Petrini, Anna Maria Granato, Elena Pancisi, Flavia Foca, Monia Dall’Agata, Isabella Bondi, Elena Amadori, Pietro Cortesi, Chiara Zani, Valentina Ancarani, Alessandro Gamboni, Antonio Polselli, Giuseppe Pasini, Daniela Bartolini, Giuseppe Maimone, Donatella Arpa, Luigino Tosatto
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundGlioblastoma (GBM) is a poor prognosis grade 4 glioma. After surgical resection, the standard therapy consists of concurrent radiotherapy (RT) and temozolomide (TMZ) followed by TMZ alone. Our previous data on melanoma patients showed that
Externí odkaz:
https://doaj.org/article/0f22af35c6464221aedfb048e9a1cf74
Autor:
Paola Ulivi, Angelo Delmonte, Elisa Chiadini, Daniele Calistri, Maximilian Papi, Marita Mariotti, Alberto Verlicchi, Angela Ragazzini, Laura Capelli, Alessandro Gamboni, Maurizio Puccetti, Alessandra Dubini, Marco Angelo Burgio, Claudia Casanova, Lucio Crinò, Dino Amadori, Claudio Dazzi
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 1, Pp 747-757 (2014)
Tyrosine kinase inhibitors (TKIs) are very efficacious in non-small-cell lung cancer (NSCLC) patients harboring activating Epidermal Growth Factor Receptor (EGFR) mutations. However, about 10% of EGFR wild type (wt) patients respond to TKI, with unkn
Externí odkaz:
https://doaj.org/article/aa48d14f07ab4dc495ac417bc830c095
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Purpose: To analyze the impact of TP53 mutations on response to first-line tyrosine kinase inhibitors (TKI) in patients with EGFR-mutated non–small cell lung cancer (NSCLC).Experimental Design: 136 EGFR-mutated NSCLC patients receiving first-line T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23d47bb549e33379e5931ad94663ae8
https://doi.org/10.1158/1078-0432.c.6525968
https://doi.org/10.1158/1078-0432.c.6525968
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Relation of TP53 mutations and clinical characteristics of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::039484f724f298b67c10c5e59cad9947
https://doi.org/10.1158/1078-0432.22465238
https://doi.org/10.1158/1078-0432.22465238
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Distribution of disruptive and non-disruptive mutations in the different types of TP53 mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11e44015238e6e527258bbb5c74f3225
https://doi.org/10.1158/1078-0432.22465241.v1
https://doi.org/10.1158/1078-0432.22465241.v1
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Association between TP53 and EGFR mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327c5e4f2f415859ce8e3780347f776c
https://doi.org/10.1158/1078-0432.22465235
https://doi.org/10.1158/1078-0432.22465235
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
ORR and DCR observed in EGFR exon 19 deleted patients in relation to TP53 mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f63894fe73e9a03752c8c467533ec0
https://doi.org/10.1158/1078-0432.22465232
https://doi.org/10.1158/1078-0432.22465232
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Supplementary legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1776a59a757395036284beb73f44e6
https://doi.org/10.1158/1078-0432.22465229
https://doi.org/10.1158/1078-0432.22465229
Autor:
Paola Ulivi, Dino Amadori, Lucio Crinò, Vienna Ludovini, Daniele Calistri, Chiara Bennati, Rita Chiari, Alessandro Gamboni, Marita Mariotti, Nicoletta De Luigi, Claudia Casanova, Laura Capelli, Maximilian Papi, Claudio Dazzi, Elisa Chiadini, Angelo Delmonte, Elisabetta Petracci, Matteo Canale
Supplementary Figure 1. a) PFS and b) OS of TP53 exon 8 mutated patients, other TP53 non-disruptive mutated patients and TP53 wt/disruptive mutated patients in the overall case series. c) PFS and d) OS of TP53 exon 8 mutated patients, other TP53 non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1056cf9950064e2534730323974a99f8
https://doi.org/10.1158/1078-0432.22465244.v1
https://doi.org/10.1158/1078-0432.22465244.v1
Autor:
Matteo Canale, Claudio Dazzi, Daniele Calistri, Sara Bravaccini, Maurizio Puccetti, Angelo Delmonte, Maximilian Papi, Paola Ulivi, Claudia Casanova, Alessandro Gamboni, Elisa Chiadini, Alessandra Dubini, Laura Capelli, Lucio Crinò, Marita Mariotti
Publikováno v:
Journal of Thoracic Disease. 10:4858-4864
Background: Molecular diagnostics for non-small cell lung cancer (NSCLC) has become the standard of care for personalized treatment. Epidermal growth factor receptor ( EGFR ) mutation and EML4-ALK translocation represent the two most important altera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29e1551f61e41dd9c0805d62ecfe30be
https://doi.org/10.21037/jtd.2018.07.22
https://doi.org/10.21037/jtd.2018.07.22